Crossmark

Sex- and gender-based personalized medicine in rheumatology

Crossref DOI link: https://doi.org/10.1038/s41584-025-01246-5

Published Online: 2025-04-07

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Volkmann, Elizabeth R. https://orcid.org/0000-0003-3750-6569
Feghali-Bostwick, Carol https://orcid.org/0000-0002-6750-6407
License Information

Text and Data Mining valid from 2025-04-07

Version of Record valid from 2025-04-07
More Information

Article History

First Online: 7 April 2025

Competing interests

: E.R.V. consults for Boehringer Ingelheim, GSK and AbbVie, all of which are outside the scope of this article.